ANN SURG ONCOL:部分非小细胞肺癌无需行系统性淋巴结清扫术

2013-01-17 ANN SURG ONCOL dxy ecoliDh5

   患者淋巴结状况分布   过去20年间,在探究小病灶肺癌中N0期状态的可靠预测因素方面进行了大量研究。然而,一直未能得到测定肿瘤体积方法的清晰阐述,并且对于亚厘米肿瘤患者是否应系统性淋巴结清扫也仍然存在着争议。为此,我国上海复旦大学附属肿瘤医院胸外科陈海泉教授与张扬博士等人进行了一项相关研究,该研究结果发表于2012年12月24日的《外科肿瘤学年鉴》(Annals of&nbsp

时间  

患者淋巴结状况分布

  过去20年间,在探究小病灶肺癌中N0期状态的可靠预测因素方面进行了大量研究。然而,一直未能得到测定肿瘤体积方法的清晰阐述,并且对于亚厘米肿瘤患者是否应系统性淋巴结清扫也仍然存在着争议。为此,我国上海复旦大学附属肿瘤医院胸外科陈海泉教授与张扬博士等人进行了一项相关研究,该研究结果发表于2012年12月24日的《外科肿瘤学年鉴》(Annals of Surgical Oncology)杂志上。

  共有243例周围型非小细胞小肺癌患者被纳入了该项研究,研究人员在对新鲜样本进行甲醛溶液固定之前进行了肿瘤体积测量,并将这些患者的淋巴结侵犯情况与临床病理学变量间的联系进行考察。并根据国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸协会(ERS)最新发布的肺腺癌分类标准,对患者样本的腺癌组织学亚型进行分类。

  研究人员发现,N1 与N2期淋巴结侵犯率分别为5.3%以及6.6 %。部分亚厘米肿瘤为N2 期(2/53, 3.8 %)。研究还发现,鳞状细胞癌、原位腺癌、微浸润腺癌、贴壁状为主的腺癌或浸润性粘液腺癌均无淋巴结转移。总体而言,该5类细胞占全部周围型小病灶非小细胞肺癌病例的34.6 %。

  陈教授等人认为,尽管通过对肿瘤体积的精确测量发现,肿瘤体积并非N0期状态的可靠预测因素。然而,超过三分之一的周围型小病灶NSCLC仍可通过组织学分类,避免进行系统性淋巴结清扫术。 


Predictive Factors of Lymph Node Status in Small Peripheral Non-small Cell Lung Cancers: Tumor Histology is More Reliable

Background

During the past two decades, many studies have sought to find reliable predictors of N0 status in small-sized lung cancers. However, the way of tumor size measurement was usually not clearly stated, and controversy remains as to whether systematic lymph node dissection should be performed in patients with subcentimeter tumors.

Methods

We reviewed correlations between lymph node involvement and clinicopathological variables in 243 small peripheral non-small cell lung cancers with their size measured in fresh specimens before formalin fixation. Histologic subtypes of adenocarcinomas were classified in line with the new International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) lung adenocarcinoma classification.

Results

Incidence of N1 and N2 nodal involvement was 5.3 and 6.6 %, respectively. N2 disease was present in a proportion of subcentimeter tumors (2/53, 3.8 %). No lymph node metastasis was revealed in squamous cell carcinomas, adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma. Collectively, the five cell types accounted for 34.6 % of all the small peripheral cases.

Conclusions

Precise measurement of tumor size in fresh tissues revealed that tumor size was not a reliable predictor of N0 status. However, through histologic classification, systematic lymph node dissection might be avoided in more than one third of small peripheral NSCLC.  



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2016888, encodeId=9863201688855, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 26 15:55:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059424, encodeId=70b72059424ff, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99381, encryptionId=2cc599381bd, topicName=非小细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Mon Jul 29 20:55:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973336, encodeId=336a19e33369d, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Thu Mar 14 22:55:00 CST 2013, time=2013-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864412, encodeId=7eca1864412c0, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Apr 12 00:55:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292924, encodeId=a17e12929246d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590170, encodeId=d69115901e090, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2016888, encodeId=9863201688855, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 26 15:55:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059424, encodeId=70b72059424ff, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99381, encryptionId=2cc599381bd, topicName=非小细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Mon Jul 29 20:55:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973336, encodeId=336a19e33369d, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Thu Mar 14 22:55:00 CST 2013, time=2013-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864412, encodeId=7eca1864412c0, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Apr 12 00:55:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292924, encodeId=a17e12929246d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590170, encodeId=d69115901e090, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2016888, encodeId=9863201688855, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 26 15:55:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059424, encodeId=70b72059424ff, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99381, encryptionId=2cc599381bd, topicName=非小细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Mon Jul 29 20:55:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973336, encodeId=336a19e33369d, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Thu Mar 14 22:55:00 CST 2013, time=2013-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864412, encodeId=7eca1864412c0, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Apr 12 00:55:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292924, encodeId=a17e12929246d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590170, encodeId=d69115901e090, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2016888, encodeId=9863201688855, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 26 15:55:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059424, encodeId=70b72059424ff, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99381, encryptionId=2cc599381bd, topicName=非小细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Mon Jul 29 20:55:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973336, encodeId=336a19e33369d, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Thu Mar 14 22:55:00 CST 2013, time=2013-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864412, encodeId=7eca1864412c0, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Apr 12 00:55:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292924, encodeId=a17e12929246d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590170, encodeId=d69115901e090, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=)]
    2013-04-12 minlingfeng
  5. [GetPortalCommentsPageByObjectIdResponse(id=2016888, encodeId=9863201688855, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 26 15:55:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059424, encodeId=70b72059424ff, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99381, encryptionId=2cc599381bd, topicName=非小细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Mon Jul 29 20:55:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973336, encodeId=336a19e33369d, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Thu Mar 14 22:55:00 CST 2013, time=2013-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864412, encodeId=7eca1864412c0, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Apr 12 00:55:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292924, encodeId=a17e12929246d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590170, encodeId=d69115901e090, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=)]
    2013-01-19 sodoo
  6. [GetPortalCommentsPageByObjectIdResponse(id=2016888, encodeId=9863201688855, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 26 15:55:00 CST 2013, time=2013-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059424, encodeId=70b72059424ff, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99381, encryptionId=2cc599381bd, topicName=非小细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Mon Jul 29 20:55:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973336, encodeId=336a19e33369d, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Thu Mar 14 22:55:00 CST 2013, time=2013-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864412, encodeId=7eca1864412c0, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Apr 12 00:55:00 CST 2013, time=2013-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292924, encodeId=a17e12929246d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590170, encodeId=d69115901e090, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Sat Jan 19 00:55:00 CST 2013, time=2013-01-19, status=1, ipAttribution=)]

相关资讯

远端胃癌淋巴结转移规律与清扫方式

  近日,福建医科大学省立临床医学院福建省立医院胃肠外科曾长青、刘进生、郑羽等人共同发表论文,旨在探讨远端胃癌的淋巴结转移规律和合理的淋巴结清扫方式。研究指出,对于远端1/3胃黏膜癌,D1清扫即可;对于浸润肌层或更深层的肿瘤,应行标准D2清扫;而对黏膜下癌,需要扩大D1+清扫的范围。该文发表在2012年第15卷第2期《中华胃肠外科杂志》上。   回顾性分析2001年1月至2010年12月间福建省